This summary is intended to highlight some of the most notable financing rounds of the month and does not intend to be integral.
Health technology companies made several important financing ads in May. Here is a list of some of the biggest financing rounds.
COHER HEALTH RELEASE $ 90 MILLION IN FUNDS OF THE SERIES C
Cohere Health, based in Boston, provides prior authorization solutions with AI to help improve the relationship between payers and suppliers. He works with about 600,000 suppliers and processes of approximately 12 million prior authorization requests each year.
The $ 90 million in funds were led by TeMek and included the support of Dferfield Management, defines Ventures, Flare Capital Partners, Longile Capital and Polaris Partners. It will help the company to climb and invest in its AI products, according to the announcement. In total, Cohere Health has raised $ 200 million.
Akido Labs ensures $ 60 million in B series funds
Akido Labs, based in Los Angeles, is a company provision and AI. It offers a product called Scopeai, which helps suppliers to diagnose patients, identify the most effective treatment and predict health risks.
The B series round of $ 60 million was directed by OAK HC/FT with the participation of Greco, SNR, and Combinator, Future Communities Capital, Jeff Dean (head scientist of Google Deepmind and Google Research), and the Integral Center for Blood and Cancer. The financing will help to climb your Scopeai product.
Sprinter Health Ennaves $ 55 million in B series funds
Sprinter Health, based in Menlo Park, California, works with health plans and offers virtual care both at home and at home. Its community -based health personnel, called Sprinters, and remote practicing nurses provide diagnostic exams, vital controls, medication management support, welfare visits and attention navigation. The sprinters are W-2 employees and are certified as phlebotomists and trained with medical assistants and skills of community health workers.
The B series round of $ 55 million was directed by Catalyst General and included the participation of Andreessen Horowitz (A16Z) Bio + Health, the Regents of the University of California, Google Ventures and Accel. The financing will help the company grow its team and expand to new geographical regions. Sprinter Health has raised more than $ 125 million in total.
Phasev raises $ 50 million in Funds from Serie A
Phasev, based in Boston, is a technology company that uses AI and automatic learning to help biofarma sponsors and contract research organizations to make precise and efficient decisions of clinical development.
The increase of $ 50 million of the company was directed by Accel and Insight Partners and included the participation of existing investors Viola Ventures, Exor and Lionbird. According to the announcement, it will help “grow its vertical AI platform to provide holistic solutions for clinical development.” The company has raised $ 65 million in total.